Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Evaxion AS EVAX

Healthcare Biotechnology
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EVAX)

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting

GlobeNewswire 8 days ago

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

GlobeNewswire November 20, 2025

Evaxion announce 2026 financial calendar

GlobeNewswire November 12, 2025

Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01

GlobeNewswire November 7, 2025

Evaxion announces business update and third quarter 2025 financial results

GlobeNewswire November 6, 2025

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

GlobeNewswire November 3, 2025

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

GlobeNewswire October 31, 2025

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

GlobeNewswire October 31, 2025

Evaxion raises $7.2 million, extending cash runway to second half of 2027

GlobeNewswire October 30, 2025
View More News ››

Opinion & Analysis (NDAQ:EVAX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EVAX)

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway,so good luck to all of you guys
coolfooldumbguy - October 15, 2025

Using technical analysis for this stock.

It is signalling a continuing uptrend for shareholders today,so good luck to all of you guys
coolfooldumbguy - September 25, 2025

Buy buddy buy because it's taking off this morning.

So that you guys should be on-board with this stock already.
coolfooldumbguy - February 4, 2025

Buy buddy buy because it's taking off this morning.

And furthermore you guys will be missing the boat  
coolfooldumbguy - January 24, 2025

EVAX ...early a.m runner up on NR

Evaxion and Pantherna announce promising preclinical mRNA vaccine data 2023-02-08 03:30 ET - News Release COPENHAGEN, Denmark and...
Iseneschal - February 8, 2023

EVAX ....8 mins to close....still time for Mr. Maggot to

turn this red ; )
Iseneschal - September 21, 2022
View more Bullboard ››

Lode Gold Resources Inc.

Lode Gold Resources Inc.

Lode Gold Resources Inc., together with its subsidiaries, engages in the acquisition and exploration of mineral resource ...
View More »